Skye Bioscience (SKYE) Stock Chart & Stock Price History $3.01 -0.24 (-7.38%) (As of 03:58 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Skye Bioscience Stock Price Performance 5 Day Performance-5.03%1 Month Performance-29.61%3 Month Performance-38.74%6 Month Performance-66.25%Year-To-Date Performance+18.01%1 Year Performance+4.14% Receive SKYE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. SKYE Stock Chart for Wednesday, December, 18, 2024 SKYE Chart by TradingView Skye Bioscience Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$3.28$3.25-0.91%$3.55$3.22150,500 shs$98.60 million12/17/2024$3.28$3.28$3.50$3.25165,500 shs$99.51 million12/16/2024$3.38$3.28-2.96%$3.48$3.25165,319 shs$99.51 million12/16/2024$3.38$3.28-2.96%$3.50$3.25165,300 shs$99.51 million12/13/2024$3.35$3.38+0.90%$3.47$3.21122,488 shs$102.54 million12/13/2024$3.35$3.38+0.90%$3.47$3.21122,600 shs$102.54 million Get the Latest News and Ratings for SKYE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$3.62$3.35-7.46%$3.70$3.24159,000 shs$101.63 million12/12/2024$3.62$3.35-7.46%$3.70$3.25159,024 shs$101.63 million12/11/2024$3.65$3.62-0.82%$3.82$3.60122,897 shs$109.82 million12/11/2024$3.65$3.62-0.82%$3.84$3.60122,800 shs$109.82 million12/10/2024$3.72$3.65-1.88%$3.98$3.52121,400 shs$110.73 million12/10/2024$3.72$3.65-1.88%$3.98$3.52121,445 shs$110.73 million12/09/2024$3.72$3.72$3.91$3.31813,300 shs$112.87 million12/09/2024$3.72$3.95+6.18%$4.02$3.62133,700 shs$119.84 million12/06/2024$3.55$3.72+4.79%$3.91$3.31813,300 shs$112.86 million12/06/2024$3.55$3.72+4.79%$3.91$3.31813,300 shs$112.86 million12/05/2024$3.85$3.55-7.79%$3.99$3.52288,100 shs$107.70 million12/05/2024$3.85$3.85$4.42$3.82246,094 shs$116.80 million12/04/2024$4.41$3.85-12.70%$4.42$3.82246,889 shs$116.81 million12/04/2024$4.41$3.85-12.70%$4.42$3.82246,800 shs$116.81 million12/03/2024$4.28$4.41+3.04%$4.58$4.23144,500 shs$133.80 million12/03/2024$4.28$4.41+3.04%$4.58$4.25144,517 shs$133.80 million12/02/2024$4.49$4.28-4.68%$4.51$4.2793,865 shs$129.85 million12/02/2024$4.49$4.28-4.68%$4.51$4.2793,800 shs$129.85 million11/29/2024$4.26$4.49+5.40%$4.59$4.2244,025 shs$136.23 million11/29/2024$4.26$4.49+5.40%$4.60$4.2244,000 shs$136.23 million11/28/2024$4.26$4.26$4.35$4.1776,133 shs$129.24 million11/28/2024$4.26$4.26$4.35$4.1776,100 shs$129.24 million11/27/2024$4.28$4.26-0.47%$4.34$4.1776,133 shs$129.25 million11/27/2024$4.28$4.26-0.47%$4.35$4.1776,100 shs$129.25 million11/26/2024$4.10$4.28+4.39%$4.33$4.0897,310 shs$129.86 million11/26/2024$4.10$4.28+4.39%$4.33$4.0897,313 shs$129.86 million11/25/2024$4.12$4.10-0.49%$4.35$4.01162,000 shs$124.39 million11/25/2024$4.12$4.12$4.22$4.07119,782 shs$125.00 million11/22/2024$4.17$4.12-1.20%$4.22$4.07119,582 shs$125.00 million11/22/2024$4.17$4.12-1.20%$4.22$4.07119,500 shs$125.00 million11/21/2024$4.28$4.17-2.57%$4.49$4.16100,800 shs$126.52 million11/21/2024$4.28$4.26-0.58%$4.49$4.2174,649 shs$129.10 million11/20/2024$4.34$4.28-1.38%$4.52$4.23107,323 shs$129.86 million11/20/2024$4.34$4.28-1.38%$4.55$4.23107,300 shs$129.86 millionHealthcare Takes A Big Step Forward With The Help of A.I. (Ad)To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the 11/19/2024$4.56$4.34-4.82%$4.68$4.3196,919 shs$131.68 million11/19/2024$4.56$4.34-4.82%$4.68$4.3197,000 shs$131.68 million11/18/2024$4.95$4.56-7.88%$5.10$4.54411,215 shs$138.35 million11/18/2024$4.95$4.56-7.88%$5.10$4.54411,200 shs$138.35 million Related Companies CYRX Stock Price Chart NGNE Stock Price Chart BTMD Stock Price Chart DSGN Stock Price Chart VYGR Stock Price Chart CTNM Stock Price Chart PROC Stock Price Chart SLRN Stock Price Chart KMDA Stock Price Chart CGC Stock Price Chart Receive SKYE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Skye Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SKYE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Skye Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Skye Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
